R J Klasa Selected Research

Cyclophosphamide (Cytoxan)

6/2000

Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R J Klasa Research Topics

Disease

1	Lymphoma (Lymphomas) 01/2001
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2001
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2001
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2000
1	Neoplasms (Cancer) 06/2000

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2001 - 06/2000
2	Antisense OligonucleotidesIBA 01/2001 - 06/2000
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2001
1	Cyclin D1IBA 01/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2001
1	alvocidib (flavopiridol)IBA 01/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2000

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2000